Enhanced immunogenicity and protective efficacy in mice following a Zika DNA vaccine designed by modulation of membrane-anchoring regions and its association to adjuvants

Zika virus (ZIKV) is a re-emerging pathogen with high morbidity associated to congenital infection. Despite the scientific advances since the last outbreak in the Americas, there are no approved specific treatment or vaccines. As the development of an effective prophylactic approach remains unaddres...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 15; p. 1307546
Main Authors Teixeira, Franciane Mouradian Emidio, Oliveira, Luana de Mendonça, Branco, Anna Cláudia Calvielli Castelo, Alberca, Ricardo Wesley, de Sousa, Emanuella Sarmento Alho, Leite, Bruno Henrique de Sousa, Adan, Wenny Camilla Dos Santos, Duarte, Alberto José da Silva, Lins, Roberto Dias, Sato, Maria Notomi, Viana, Isabelle Freire Tabosa
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Zika virus (ZIKV) is a re-emerging pathogen with high morbidity associated to congenital infection. Despite the scientific advances since the last outbreak in the Americas, there are no approved specific treatment or vaccines. As the development of an effective prophylactic approach remains unaddressed, DNA vaccines surge as a powerful and attractive candidate due to the efficacy of sequence optimization in achieving strong immune response. In this study, we developed four DNA vaccine constructs encoding the ZIKV prM/M (pre-membrane/membrane) and E (envelope) proteins in conjunction with molecular adjuvants. The DNA vaccine candidate (called ZK_ΔSTP), where the entire membrane-anchoring regions were completely removed, was far more immunogenic compared to their counterparts. Furthermore, inclusion of the tPA-SP leader sequence led to high expression and secretion of the target vaccine antigens, therefore contributing to adequate B cell stimulation. The ZK_ΔSTP vaccine induced high cellular and humoral response in C57BL/6 adult mice, which included high neutralizing antibody titers and the generation of germinal center B cells. Administration of ZK-ΔSTP incorporating aluminum hydroxide (Alum) adjuvant led to sustained neutralizing response. In consistency with the high and long-term protective response, ZK_ΔSTP+Alum protected adult mice upon viral challenge. Collectively, the ZK_ΔSTP+Alum vaccine formulation advances the understanding of the requirements for a successful and protective vaccine against flaviviruses and is worthy of further translational studies.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Daniela Hozbor, Institute of Biotechnology and Molecular Biology (IBBM), Argentina
These authors share senior authorship
Kar Muthumani, GeneOne Life Science, Inc., Republic of Korea
Reviewed by: James Drew Brien, University of Kentucky, United States
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2024.1307546